Stay updated on SNDX-6352 in Active cGVHD Clinical Trial
Sign up to get notified when there's something new on the SNDX-6352 in Active cGVHD Clinical Trial page.

Latest updates to the SNDX-6352 in Active cGVHD Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page displays the completed axatilimab study record, including its eligibility criteria, treatment plan, outcomes, locations, and supporting documents.SummaryDifference60%

- Check8 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check15 days agoChange DetectedA site-wide NIH notice announces a website transition and says both “Artificial Intelligence” and “Super Intelligence” may appear in NIH content during the transition.SummaryDifference1%

- Check22 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the expected content, and the Home navigation link has been removed from the site footer/navigation.SummaryDifference0.5%

Stay in the know with updates to SNDX-6352 in Active cGVHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-6352 in Active cGVHD Clinical Trial page.